文献速递哮喘

17国成人哮喘、花粉症和湿疹负担:GAN第一阶段研究

The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
PubMed 文献 · Eur Respir J · 2022-09-15

研究提示这三种疾病负担显著,需重视预防和公平治疗。

要点

  • 成人当前喘息总体患病率为6.6%,范围0.9-32.7%。
  • 曾患花粉症患病率最高,达14.4%,范围2.8-45.7%。
  • 疾病负担在国家间和国家内中心间差异均很大。

核心结论

  • 所调查国家成人哮喘、花粉症和湿疹负担显著,具有重要公共卫生意义。

研究设计与样本

  • 多国横断面人群研究,采用与国际儿童哮喘和过敏性疾病研究第三阶段相同的核心方法。

主要发现

  • 当前喘息总体患病率为6.6%(范围0.9-32.7%)。
  • 曾患哮喘总体患病率为4.4%(范围0.9-29.0%)。
  • 曾患花粉症总体患病率为14.4%(范围2.8-45.7%)。
  • 曾患湿疹总体患病率为9.9%(范围1.6-29.5%)。
  • 中心间患病率在国家间和国家内差异均很大;曾患花粉症与曾患哮喘、曾患湿疹与曾患花粉症在中心水平呈中度相关。

关键数值与推荐

  • 当前喘息总体患病率6.6%(范围0.9-32.7%)。
  • 曾患哮喘总体患病率4.4%(范围0.9-29.0%)。
  • 曾患花粉症总体患病率14.4%(范围2.8-45.7%)。
  • 曾患湿疹总体患病率9.9%(范围1.6-29.5%)。

临床怎么用

  • 应重视成人哮喘、花粉症和湿疹的疾病负担,制定预防策略并保障有效且可负担治疗的公平可及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Asthma, hay fever and eczema are three common chronic conditions. There have been no recent multi-country data on the burden of these three conditions in adults; the aims of this study are to fill this evidence gap. METHODS: The Global Asthma Network Phase I is a multi-country cross-sectional population-based study using the same core methodology as the International Study of Asthma and Allergies in Childhood Phase III. It provides data on the burden of asthma, hay fever and eczema in children and adolescents, and, for the first time, in their parents/guardians. RESULTS: Data were available from 193 912 adults (104 061 female; mean±sd age 38±7.5 years) in 43 centres in 17 countries. The overall prevalence (range) of symptoms was 6.6% (0.9-32.7%) for current wheeze, 4.4% (0.9-29.0%) for asthma ever, 14.4% (2.8-45.7%) for hay fever ever and 9.9% (1.6-29.5%) for eczema ever. Centre prevalence varied considerably both between countries and within countries. There was a moderate correlation between hay fever ever and asthma ever, and between eczema ever and hay fever ever at the centre level. There were moderate to strong correlations between indicators of the burden of disease reported in adults and the two younger age groups. CONCLUSION: We found evidence for a substantial burden of asthma, hay fever ever and eczema ever in the countries examined, highlighting the major public health importance of these diseases. Prevention strategies and equitable access to effective and affordable treatments for these three conditions would help mitigate the avoidable morbidity they cause.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Mortimer K, Lesosky M, García-Marcos L, et al. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. Eur Respir J. 2022. PMID: 35210319. doi:10.1183/13993003.02865-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。